| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |